Loading clinical trials...

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04503707

Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice

The aim of the study is to explore how the individualized dosing regimen of REKOVELLE is used in routine clinical practice and to describe the effectiveness and safety of REKOVELLE under real-world co...

Lead sponsor: Ferring Pharmaceuticals•14 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.

NCT03564509 · Controlled Ovarian Stimulation

UNKNOWN

N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS

NCT04122729 · In Vitro Fertilization, Controlled Ovarian Stimulation

COMPLETEDPhase 4

To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran®

NCT03051087 · Controlled Ovarian Stimulation

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 14, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment250

Start dateJun 2020

Last updatedDec 14, 2021

Condition

Controlled Ovarian Stimulation

Locations shown

Hôpital Pellegrin

Bordeaux

Hôpital Femme Mère Enfant

Bron

Hopital Antoine Béclère

Clamart

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 14, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions